glp-1 therapy for weight loss First 90 Days on Therapy: What to Expect Guide 3 Takeaways from the Landmark

At Elite Primary Care Group, our experienced providers will work closely with you to determine which medication may be best suited to your unique health needs and goals

The effects may last 24 to 72 hours

The fixed dose combination of 90-mg ledipasvir and 400-mg sofosbuvir is sold under the trade name Harvoni (Gilead Sciences) and is recommended as first-line therapy by the American Society for the Study of Liver Disease (AASLD) for the treatment of HCV genotypes 1a, 1b, and 4

Wegovy is a prescription weight loss medication approved by the US Food and Drug Administration (FDA) to help adults with obesity or overweight and obese adolescents aged 12 and older with their weight-related concerns